首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical oncology

缩写:CLIN ONCOL-UK

ISSN:0936-6555

e-ISSN:1433-2981

IF/分区:2.5/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引2782
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
D Johnston,O McLaughlin,J Tee et al. D Johnston et al.
Aims: Stereotactic radiosurgery (SRS) has been adopted as an important component of brain metastasis management. Appropriate patient selection and prognostication can prove to be challenging. We set out to analyse SRS out...
A Tahmasebzadeh,E Yazdani,R Mirshahi et al. A Tahmasebzadeh et al.
Aims: Uveal melanoma (UM) is the most common intraocular malignancy in adults, with local recurrence probability depending on treatment center strategies, radioisotopes, and follow-up period after conservative treatments ...
M Ebadi,X Fan,G Schoch et al. M Ebadi et al.
Aims: In the era of chimeric antigen receptor T-cell (CAR-T) therapy, there remains a role for autologous stem cell transplant (ASCT) for patients with large B-cell lymphoma (LBCL) without access to CAR T-cell therapy or ...
D Kawahara,A S Koganezawa,H Yamaguchi et al. D Kawahara et al.
Aims: To introduce a Biological Adaptive Radiotherapy (BART) framework that incorporates biological effects into adaptive planning, quantify the impact of a short intrafraction interruption on biologically effective dose ...
J King,C Barker,A Wright et al. J King et al.
Aims: The use of stereotactic radiosurgery (SRS) to treat patients with intracranial metastatic disease is increasing. Despite efforts to standardise practice across the centres delivering SRS in the UK, evidence suggests...
K Franks,D Smith,P Shaw et al. K Franks et al.
Aims: The aim of this study was to describe the clinical outcomes, demographics, and clinical characteristics of patients with locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) treated with durv...